Good company but losing its value - Regulatory Sanofi Employee Review

3.0
May 24, 2020
Recommend
CEO approval
Business Outlook

Pros

good work life balance (Allowed 2 days a week per company policy) Plenty of time off (not carried over) option to work remotely interesting projects if you are in the right group Most people are good to work with

Cons

no longer reimburse for Masters Lots of people leaving left and right recently. Don't believe the reviews here which have no cons. not enough pay raises or pay itself --leading to a huge amount of people leaving their positions in all departments. This eventually hurts the products being worked on. If you don't have a pHD, you can't grow your career into a Scientist level role in the lab with just a Masters degree, be warned. US folks seem to have to work harder than their French counterparts.

Explore other reviews about Sanofi

5.0
Feb 25, 2026
Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

Good benefits (9% 401k match, company car, solid insurance). Huge company with many therapeutic areas you can choose from. I like my coworkers.

Cons

Employee stock purchase plan is nice in theory, but stock has treaded water for many years. A very big company with lots of big pharma metrics to meet. Pay is maybe slightly below industry average.

3.0
Jul 1, 2026
Recommend
CEO approval
Business Outlook

Pros

Extensive and active employee resource groups, strong leadership development opportunities, clear company mission, gig opportunities that support career development, strong employee support through the ombuds office and compliance help line, and stable company portfolio.

Cons

No work-life balance considerations with hybrid work model, contradictions in company mission compared to policies (i.e., target to reduce carbon emissions with employee commuting to office as one of the top 5 causes but yet still requiring employees to commute to office 3 days a week), some office sites are not conducive to in office productivity (not enough privacy or space), compensation package is not competitive for MA pharmaceutical companies, long-term incentives have almost no value once they are vested, health care benefits require employees to jump through hoops to maximize discounts or qualify for coverage of certain medications, and accountability for department leadership to follow the corporate leadership pillars is inconsistent across departments.

See reviews by: Helpful|Rating|Date|All